期刊文献+

冠心病患者血清抗心磷脂抗体变化与血脂的关系 被引量:2

The relationship of change of anticardiolipin antibody and blood lipid in patients with coronary heart disease
下载PDF
导出
摘要 目的 :探讨抗心磷脂抗体 (ACA)在冠心病 (CHD)发病中的意义及其与血脂的关系。方法 :5 2例 CHD患者及44名健康体检者分别用 EL ISA和免疫透射比浊法测定血清 ACA- Ig G,ACA- Ig M,ACA- Ig A和 TC,TG,HDL,Apo A- I,Apo B的含量。结果 :冠心病组的 ACA- Ig G水平明显高于正常对照 (P<0 .0 1) ,而 ACA- Ig G变化的水平与 TG,HDL,Apo A- I改变呈显著的相关关系 (r分别为 0 .31,- 0 .2 7和 - 0 .2 9,均 P<0 .0 1)。结论 :血清 ACA-Ig G可与血脂代谢紊乱可能共同形成 CHD的发病机制或有促进血脂代谢紊乱的作用。 AIM:To study the role of anticardiolipin antibody (ACA) in coronary heart disease(CHD) and the relationship of blood lipid in CHD patients . METHODS: Serum ACA IgG, IgM,IgA and TC,TG,HDL,ApoA I,ApoB were measured by ELISA and immune turbidity assay in 52 CHD patients and in 44 healthy people. RESULTS: The levels of ACA IgG of the CHD group were markely higher than those of the control group( P <0.01) and changes in ACA IgG levels of were closely associated with TG,HDL,ApoA I ( r =0.31, P <0.01, 99% CI 0.05~0.53; r = -0.27, P <0.01, 99% CI -0.01~-0.49; r =-0.29, P <0.01, 99% CI -0.03~-0.51). CONCLUSION: The high level serum ACA IgG autoantibody may play a role mediated pathogenesis of CHD.
出处 《心脏杂志》 CAS 2001年第1期50-51,共2页 Chinese Heart Journal
关键词 冠状动脉疾病 抗心磷脂抗体 血脂 coronary disease anticardiolipin antibody blood lipid
  • 相关文献

参考文献6

二级参考文献10

  • 1高大中,罗开良,何生玉.抗心磷脂抗体与心脏病变关系的初步探讨[J].四川医学,1993,14(6):345-347. 被引量:2
  • 2邓宇斌,中国病理生理杂志,1996年,12卷,4期,432页
  • 3邓宇斌,中国免疫学杂志,1996年,12卷,5期,246页
  • 4许以华,中华内科杂志,1992年,6卷,373页
  • 5Wang M X,J Immunol,1995年,155卷,1629页
  • 6Gao B,Gene,1993年,126卷,287页
  • 7邓宇斌,上海免疫学杂志,1997年,17卷,1期,6页
  • 8李婉先,流行病学,1986年,380页
  • 9Aoyama Y,Nucleic Acids Res,1989年,17卷,15期,6401页
  • 10霍海洋,胡健,齐国光,曾定尹,张明.血脂诸危险因素与冠心病之间关系的研究[J].中国公共卫生学报,1997,16(3):132-133. 被引量:3

共引文献28

同被引文献17

  • 1王丽凤,郑延松,刘文艳.D-二聚体与急性冠脉综合征[J].临床内科杂志,2006,23(5):359-360. 被引量:13
  • 2李琪玲,杨益.抗心磷脂抗体的研究进展[J].淮海医药,2006,24(4). 被引量:4
  • 3Hopkins P, Hunt S, Schiner P, et al. Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study[J]. Atherosclerosis, 1998,141 : 333-- 345.
  • 4Mary S, Ayrs S, Humphrie S, et al. Lipoprotein(a) as a predictor of myocardial infarction in middle-aged men[J]. Am J Med, 2001,110 (1) :22-- 27.
  • 5Von Eckardstein, Schulte H, Cullen P, et al. Lipoprotein(a) farther increase the risk of coronary events in men with high global cardiovascular risk[J]. J Am Coll Cardiol, 2001,37(2):434--439.
  • 6Buechler C, Vllrich H. Lipoprotein (a) up-- regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes[J]. Blood, 2001,97 (4) : 981 -- 986.
  • 7Lundstam O, Hart Camejo G. Proteoglycans' contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix[J]. Arterioscler Thromb Vasc Biol, 1999,19:1162--1167.
  • 8Kalina A, Csaszer A, Fust G, et al. The association of serum lipoprotein ( a ) levels, apolipoprotein ( a ) size and (TTTTA) n polymorphism with coronary heart disease[J]. Clin Chim Acta,2001,309 (1):45-- 51.
  • 9Gaw A, Brown EA, Docherty G, et al. Is. lipoprotein (a) cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from The West of Scotland Coronary Prevention Study[J]. Atherosclerosis, 2000,148:95--100.
  • 10Cantin B, Gagnon F, Moorjani S, et al.Lipoprotein(a) and in-dependent risk factor for ischaemic heart disease in men? The Quebec Cardiovascular Study[J]. J Am Coll Cardiol, 1998,31:519--525.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部